Akt inhibitor MK2206 selectively targets CLL B‐cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis. (20th September 2013) - Ding, Wei; Shanafelt, Tait D.; Lesnick, Connie E.; Erlichman, Charles; Leis, Jose F.; Secreto, Charla; Sassoon, Traci R.; Call, Timothy G.; Bowen, Deborah A.; Conte, Michael; Kumar, Shaji; Kay, Neil E.